Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

29.30

+0.86 (3.02%)

At close: Feb 9, 2026, 4:00 PM EST

29.20

-0.10 (-0.34%)

After-hours: Feb 9, 2026, 6:15 PM EST

Viking Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 9, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,312	4,484	1,862	721	360	411
Market Cap Growth	-14.94%	140.89%	158.23%	100.31%	-12.38%	-29.13%
Enterprise Value	2,588	3,555	1,487	567	144	156
Last Close Price	28.44	40.24	18.61	9.40	4.60	5.63
PB Ratio	4.49	5.09	5.34	4.96	1.78	1.68
P/TBV Ratio	4.63	5.09	5.34	4.96	1.78	1.68
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0	0.00
Quick Ratio	27.41	32.93	18.92	7.09	23.02	20.48
Current Ratio	28.34	33.09	19.19	7.61	23.98	21.12
Return on Equity (ROE)	-29.23%	-17.90%	-34.79%	-39.67%	-24.65%	-15.15%
Return on Assets (ROA)	-20.48%	-14.77%	-23.47%	-23.19%	-14.90%	-9.86%
Return on Capital Employed (ROCE)	-38.50%	-17.10%	-28.90%	-48.00%	-27.60%	-17.50%
Earnings Yield	-7.19%	-2.45%	-4.61%	-9.55%	-15.28%	-9.62%
Buyback Yield / Dilution	-5.48%	-15.57%	-22.79%	0.47%	-6.34%	-0.89%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q